Dr. Nasim Parsa, MD

Dr. Parsa practices at M Health Fairview Clinics and Surgery Center - Minneapolis in Minneapolis, Minnesota.

Dr. Parsa's NPI, 1275943631, was assigned on May 6, 2014. Dr. Parsa holds Minnesota license 71812.

Dr. Parsa's primary practice is M Health Fairview Clinics and Surgery Center - Minneapolis, at 909 Fulton Street Southeast, Minneapolis, MN 55455. The practice phone is (612) 676-5500.

Dr. Parsa's primary practice is M Health Fairview Clinics and Surgery Center - Minneapolis in Minneapolis, Minnesota. Dr. Parsa is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Parsa to 1 more hospital, 3 group practices and clinics, 3 medical groups and 1 ambulatory surgery center, each named with a free account. Dr. Parsa's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parsa practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Parsa's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Parsa is licensed in Minnesota.

CMS data shows 162 Medicare services from Dr. Parsa across 5 procedure codes in 2024, for 149 Medicare patients. Medicare paid $9,546 for them.

CMS counts 149 Medicare patients who saw Dr. Parsa in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parsa's median patient age at 61, with 55% women.

In 2024, Dr. Parsa wrote 334 Medicare Part D claims for 133 patients. 96% of them were for generic drugs. CMS names the drug for 242 of them, across 3 drugs with 11 or more claims each, at $5,519 in total drug cost. In 2023, CMS named 184 claims across 3 drugs.

Dr. Parsa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Parsa as offering telehealth. CMS counts 82 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Parsa, more than 72% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 34 papers to Dr. Parsa, published from 2017 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Colonoscopy, Artificial Intelligence and Esophageal Achalasia. Dr. Parsa has published most often in Endoscopy. Dr. Parsa's most frequent co-authors are Mouen A. Khashab, MD, Jose M. Nieto, DO and Olaya Isabella Brewer Gutierrez, MD.

CMS Open Payments shows 52 general payments to Dr. Parsa from 13 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 47% of the total. Phathom Pharmaceuticals, Inc. paid the most, $12,558.